Spinal analgesics

Anesthesiology Clinics of North America

Volumn 21, Issue 4, 2003, Pages 805-816

  Nguyen, Hollie ^a   Garber, Jason E ^a   Hassenbusch, Samuel J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; ACETYLCHOLINESTERASE; BUPIVACAINE; CLONIDINE; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; FENTANYL; KETAMINE; LOCAL ANESTHETIC AGENT; MEMANTINE; METHADONE; MIDAZOLAM; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEOSTIGMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; OCTREOTIDE; OMEGA CONOTOXIN MVIIA; OPIATE AGONIST; PETHIDINE; SEROTONIN; SUFENTANIL; TETRACAINE; TIZANIDINE; UNINDEXED DRUG; VAPREOTIDE;

AGITATION; ANALGESIC ACTIVITY; ANAPHYLAXIS; ANTINOCICEPTION; BODY TEMPERATURE DISORDER; CHRONIC PAIN; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DYSPHORIA; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HISTAMINE RELEASE; HUMAN; HYDROPHILICITY; HYPOTENSION; IMPOTENCE; LETHARGY; LIPID SOLUBILITY; LOW BACK PAIN; MALAISE; NAUSEA; NEUROMODULATION; NEUROTOXICITY; NOCICEPTION; NYSTAGMUS; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; SPINAL ANESTHESIA; URINARY HESITANCY; URINE RETENTION; VOMITING;

EID: 0347363508     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(03)00091-9     Document Type: Review

References (52)

1. Krames ES. Spinal admistration of opioids for non-malignant pain: a United States experience. In: Winnie A, Waldman S, editors. International Pain Management. Philadelphia: WB Saunders; 1996. p. 443-6.
2. D'Amours RH, et al. Perioperative drugs and postoperative pain management. Anesthesiol Clin N Am 1997;15:251-68.
3. Payne R, Gradert TL, Inturris C, et al. Cerebral spinal fluid distribution of opioids after intraventricular and lumbar subarachnoid administration in sheep. Life Sci 1996;59:1307-21.
4. Anderson VC, Burchiel K. A Prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289-300.
5. Bennett G, Burchiel K, Buschser E. Clinical guidelines for instraspinal infusion: report of an expert panel. J Pain Symptom Manag 2000;20(Suppl 2):37-43.
6. Bowdle TA. Adverse effects of opioid agonists and agonists-antagonists in anesthesia. Drug Saf 1998;19:173-89.
7. Bennett G, Serafini M, Burchiel K. Evidence-based review of the literature on intrathecal delivery of pain medications. J Pain Symptom Manag 2000;20(Suppl 2):S12-36.
8. Aldrete JA, Brown CA, Yharcho KL. Cervical radiculopathy treated by infusion of epidural analgesics in homebound patients. J Clin Anesth 1994;6:35-42.
9. Monk JP, Beresford R, Ward A. Sufentanil. A review of its pharmacologie properties and therapeutic use. Drugs 1998;36:286-313.
10. Gregg R. Spinal analgesia. Anesth Clin North Am 1989;7:79-100.
11. Levi F, Misset J, Brienza S, et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using ambulatory multichannel programmable pump. Chronotherapy for colorectal cancer. Cancer 1992 Feb 15;69(4):893-900.
12. Hardy P, Wells JC. Continuous intrathecal lidocaine infusion analgesia: a case report of a nine week spinal. Pallative Med 1989;3:23-5.
13. Sjoberg M, Nitescu P, Appelgren L, et al. Long-term intrathecal morphine and bupivicaine in "refractory" cancer pain. Results from the first series of 52 patients. Acta Anaes Scand 1991; 35:30-43.
14. Berde CB, Sethna NF, Conrad LS, et al. Subarachnoid Bupivacaine analgesia for seven months for a patient with a spinal cord tumor. Anesthesiology 1990;72:1094-6.
15. Krames ES, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without Bupivicaine. J Pain and Symp Manag 1993;8: 539-48.
16. Appelgren L, Janson M, Nitescu P, et al. Continuous intracistemal and high cervical intrathecal Bupivicaine analgesia in refractory head and neck pain. Anesthesiology 1996;84:256-72.
17. Mollenholt P, Rawal N, Gordh Jr T, et al. Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathologic investigations of spinal cord and nerve roots. Anesthesiology 1994;81:534-42.
18. Penn RD, Paice JA, Kroin JS, et al. Octreotide: a potent new non-opioid analgesic for intrathecal infusion. Pain 1992;51(2):261-2.
19. Penn RD. Intrathecal octreotide for cancer pain. Lancet 1990;335(8691):738.
20. Eisenach JC, Dupen S, Dubois M. Epidural clonidine analgesia for intractable cancer pain. Pain 1995;61:391-9.
21. Eisenach J, Rauck R, Buzzanell C, et al. Epidural Clonidine analgesia for intractable cancer pain: phase I. Anesthesiology 1989;71:647-52.
22. Siddall PJ, Gray M, Rutkowski S, et al. Intrathecal clonidine and the management of spinal cord injury pain: a case report. Pain 1994;59:147-8.
23. Coombs DW, Saunders RL, Fratkin JD, Jensen LE, Murphy CA. Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. J Neurosurg 1986;64(6):890-4.
24. Coombs DW, Saunders RL, Lachance D, Savage S, Ragnarsson TS, Jensen LE. Intrathecal morphine tolerance:use of intrathecal clonidine DADLE, and intraventricular morphine. Anesthesiology 1985;62(3):358-63.
25. Malinovsky JM, Lepage JY, Cozian A, Bernard JM, Pinaud M. Intrathecal clonidine as sole anesthetic agent for surgery. Reg Anesth 1993;18(Suppl 15).
26. Filos KS, Goudas LC, Patroni O, Polyzou V. Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Reg Anesth 1993;18(Suppl 18).
27. Van Essen EJ, Bovill JG, Ploeger EJ, Beerman H. Intrathecal morphine and clonidine for control of intractable cancer pain: A case report. Acta Anaesthesiol Belg 1988;39(2):109-12.
28. Hassenbusch SJ, Dickens M. Neuraxial Drug Infusion. In: Batjer HH, Loftus CM, editors. Textbook of neurological surgery, vol. 4. Philadelphia: Lippincott and Raven; 2003. p. 3042.
29. Fibuch EE. Uncommon applications for continuous spinal anesthesia. Regional anesthesia 1993; 18(Suppl 6):419-23.
30. Abram SE. Continuous spinal anesthesia for cancer and chronic pain. Regional Anesthesia 1993; 18(Suppl 6):406-13.
31. Rouck RL, et al. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1994;80(5):1181-2.
32. Hassenbusch SJ, Gunes S, Wachsman S, et al. Intrathecal clonidine in the treatment of intractable pain: a phase I/II study. Pain medicine 2002;3(2):85-91.
33. Wulf H, Gleim M, Mignat C, et al. The stability of mixtures of morphine hydrochloride, bupivicaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. J Pain Sym Manag 1994;9:308-11.
34. Malmberg AB, Yaksh TL. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 1995;60(1):83-90.
35. Yang CY. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anesthesia 1996;43(4):379-83.
36. Kristensen JD, Svensson B, Grodh Jr T, et al. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992;51(2):249-53.
37. Wu HH, Lester BR, Sun Z, et al. Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord. Pain 1994;56(2):203-10.
38. Winnie AP, Pappas GD, Das Gupta TK, et al. Subarachnoid adrenal medullary transplants for terminal cancer pain. A report of preliminary studies. Anesthesiology 1993;79(4):644-53.
39. Yaksh TL, Grafe MR, Malkmus S, et al. Studies on the safety of chronologically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 1995;82(2):412-27.
40. Bouaziz H, Tong C, Eisenach JC, et al. Postoperative analgesia from intrathecal neostigine in sheep. Anesthesia and Analgesia 1995;80(6):1140-4.
41. Hood DD, Eisenach JC, Tuttle R, et al. Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology 1995;82(2):331-43.
42. Hersh EV, Maniar M, Green M, et al. Anesthetic activity of the lipospheres bupivacaine delivery system in the rat. Anesth Prog 1993;39(6):197-200.
43. Boogaerts JG, Lafont ND, Declercq AG, et al. Epidural administration of liposome-associated bupivicaine for the management of postsurgical pain: a first study. J Clin Anesthesiol 1994; 6(4):315-20.
44. Langerman L, Grant GJ, Zakowski M, et al. Prolongation of spinal anesthesia. Differential action of a lipid drug carrier on tetracaine, lidocaine, and procaine. Anesthesiology 1992;77(30): 475-81.
45. Langerman L, Golomb E, Benita S, et al. Spinal anesthesia: significant prolongation of the pharmacologic effect of tetracaine with lipid solution of the agent. Anesthesiology 1991;74(1): 105-97.
46. Masters DB, Berde CB, Dutta SK, et al. Prolonged regional nerve blockade by controlled release of local anesthetic from biodegradable polymer matrix. Anesthesiology 1993;79(2):340-6.
47. Hassenbusch SJ, Stanton-Hicks M, Covington E, Walsh J, Guthrey D. Long-term Intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manag 1995;10(7): 527-41.
48. Weissman DE, Haddox JP. Opioid pseudoaddiction: an iatroenic syndrome. Pain 1989;36: 363-6.
49. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11:71-9.
50. Onofrio B, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 55 patients. J Neurosurg 1990;72:200-9.
51. Hassenbusch SJ, Pillay PK, Magdinec M, et al. Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 1990;73:405-9.
52. Winkelmuller M, Winklemuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-67.